• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: A call for action on the development and implementation of new methodologies for safety assessment of chemical-based products in the EU - A short communication.

作者信息

Cronin Mark, Doe John, Pereira Marina, Willett Catherine

机构信息

Chemoinformatics Research Group, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK.

Chemoinformatics Research Group, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK.

出版信息

Regul Toxicol Pharmacol. 2021 Jun;122:104911. doi: 10.1016/j.yrtph.2021.104911. Epub 2021 Mar 2.

DOI:10.1016/j.yrtph.2021.104911
PMID:33662477
Abstract
摘要

相似文献

1
Re: A call for action on the development and implementation of new methodologies for safety assessment of chemical-based products in the EU - A short communication.关于：呼吁在欧盟对基于化学品的产品进行安全评估的新方法的开发与实施采取行动——一篇简短通讯。
Regul Toxicol Pharmacol. 2021 Jun;122:104911. doi: 10.1016/j.yrtph.2021.104911. Epub 2021 Mar 2.
2
A call for action on the development and implementation of new methodologies for safety assessment of chemical-based products in the EU - A short communication.呼吁在欧盟制定和实施新的化学产品安全评估方法方面采取行动——简短交流。
Regul Toxicol Pharmacol. 2021 Feb;119:104837. doi: 10.1016/j.yrtph.2020.104837. Epub 2020 Nov 26.
3
Risk assessment of nanomaterials in cosmetics: a European union perspective.化妆品纳米材料风险评估：欧盟视角。
Arch Toxicol. 2012 Nov;86(11):1641-6. doi: 10.1007/s00204-012-0944-x. Epub 2012 Oct 2.
4
Estimating chemical ecotoxicity in EU ecolabel and in EU product environmental footprint.估算欧盟生态标签和欧盟产品环境足迹中的化学生态毒性。
Environ Int. 2018 Sep;118:44-47. doi: 10.1016/j.envint.2018.05.022. Epub 2018 May 22.
5
A decade of marketing approval of gene and cell-based therapies in the United States, European Union and Japan: An evaluation of regulatory decision-making.美国、欧盟和日本基因和细胞治疗药物上市批准十年来的监管决策评估
Cytotherapy. 2018 Jun;20(6):769-778. doi: 10.1016/j.jcyt.2018.03.038. Epub 2018 May 2.
6
Regulatory issues in management of chemicals in OECD member countries.经合组织成员国化学品管理中的监管问题。
Front Biosci (Elite Ed). 2013 Jan 1;5(1):375-98. doi: 10.2741/e622.
7
Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.加强和合理化欧盟的药物警戒：欧洲将走向何方？对新的欧盟药物警戒立法的审查。
Drug Saf. 2011 Mar 1;34(3):187-97. doi: 10.2165/11586620-000000000-00000.
8
Call for More Effective Regulation of Clinical Trials with Advanced Therapy Medicinal Products Consisting of or Containing Genetically Modified Organisms in the European Union.呼吁在欧盟内对包含或含有基因修饰生物体的先进治疗药物产品的临床试验进行更有效的监管。
Hum Gene Ther. 2021 Oct;32(19-20):997-1003. doi: 10.1089/hum.2021.058. Epub 2021 May 24.
9
Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States.比较欧盟和美国批准先进疗法的监管途径。
Cytotherapy. 2021 Mar;23(3):261-274. doi: 10.1016/j.jcyt.2020.11.008. Epub 2021 Jan 19.
10
Evaluation of post-authorization safety studies in the first cohort of EU Risk Management Plans at time of regulatory approval.监管批准时评估监管批准时第一批欧盟风险管理计划中的上市后安全性研究。
Drug Saf. 2009;32(12):1175-87. doi: 10.2165/11318980-000000000-00000.

引用本文的文献

1
A matter of trust: Learning lessons about causality will make qAOPs credible.信任问题：吸取因果关系的教训将使定量构效关系可信。
Comput Toxicol. 2022 Feb;21:100205. doi: 10.1016/j.comtox.2021.100205.